1 Fraile-Bethencourt et al (2019); 2 Fraile-Bethencourt et al (2017); 3 Acedo et al (2015); 4 Sanoguera-Miralles et al (2024); 5 Valenzuela-Palomo et al (2022); 6 Bueno-Martínez et al (2022); 7 Sanoguera-Miralles et al (2020); 8 Bueno-Martínez et al (2021).
The CHEK2, PALB2, ATM, RAD51C and RAD51D minigenes have been developed under the H2020 grant “Breast Cancer Risk after Diagnostic Gene Sequencing (BRIDGES)” (Project Number 634935).
9 Lara et al (2014); 10 Villate et al (2018); 11 Gailite et al (2020); 12 Zhu et al (2022).